HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B

Active, not recruitingOBSERVATIONAL
Enrollment

201

Participants

Timeline

Start Date

February 1, 2011

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Hepatitis B
Trial Locations (12)

23298

Virginia Commonwealth University, Richmond

27599

University of North Carolina, Chapel Hill

55446

University of Minnesota, Plymouth

55905

Mayo Clinic Rochester, Rochester

75390

University of Texas Southwestern, Dallas

94107

California Pacific Medical Center, San Francisco

94143

University of California San Francisco Medical Center, San Francisco

98101

Virginia Mason Medical Center, Seattle

98104

Harborview Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

02115

Beth Israel Deaconess Medical Center, Boston

ON M5G 1X8

University of Toronto, Toronto

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pennsylvania

OTHER

NCT01298037 - HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B | Biotech Hunter | Biotech Hunter